A detailed history of Pnc Financial Services Group, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,737 shares of LEGN stock, worth $89,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,737
Previous 1,987 37.75%
Holding current value
$89,718
Previous $88,000 51.14%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$43.55 - $59.88 $32,662 - $44,910
750 Added 37.75%
2,737 $133,000
Q2 2024

Aug 09, 2024

BUY
$39.5 - $57.22 $30,217 - $43,773
765 Added 62.6%
1,987 $88,000
Q1 2024

May 10, 2024

BUY
$55.06 - $69.99 $10,791 - $13,718
196 Added 19.1%
1,222 $68,000
Q4 2023

Feb 09, 2024

SELL
$57.25 - $69.74 $18,434 - $22,456
-322 Reduced 23.89%
1,026 $61,000
Q3 2023

Nov 13, 2023

BUY
$63.16 - $76.5 $29,811 - $36,108
472 Added 53.88%
1,348 $90,000
Q2 2023

Aug 11, 2023

BUY
$46.28 - $75.01 $17,077 - $27,678
369 Added 72.78%
876 $60,000
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $7,251 - $9,580
167 Added 49.12%
507 $24,000
Q4 2022

Feb 10, 2023

SELL
$38.8 - $55.46 $388 - $554
-10 Reduced 2.86%
340 $16,000
Q3 2022

Nov 10, 2022

BUY
$38.15 - $57.1 $8,660 - $12,961
227 Added 184.55%
350 $14,000
Q2 2022

Aug 12, 2022

BUY
$33.54 - $55.0 $1,408 - $2,310
42 Added 51.85%
123 $6,000
Q1 2022

May 12, 2022

SELL
$31.02 - $48.18 $7,134 - $11,081
-230 Reduced 73.95%
81 $2,000
Q4 2021

Feb 11, 2022

BUY
$41.14 - $56.98 $12,794 - $17,720
311 New
311 $14,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.